Leptomeningeal metastasis from an intracranial epidermoid cyst
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Epidermoid tumors are benign and constitute 1% of all intracranial tumors. Squamous cell carcinoma (SCC) arising in an epidermoid is rare, and leptomeningeal metastasis (LM) from malignant degeneration of an epidermoid is even less common; we have identified only three such patients in the literature.1-3⇓⇓
Demonstration of cancer cells in the CSF is the diagnostic “gold standard” for LM. Sensitivity of a single test is 50 to 60%, but improves to 85% with repeated testing.4 Typical findings on MRI scan can establish the diagnosis of LM without CSF cytology, but only in patients with a known cancer. CSF tumor marker analysis may improve diagnostic sensitivity.5,6⇓ We report a patient who developed LM from malignant degeneration of an epidermoid cyst, had elevated CSF tumor markers, and had persistently negative CSF cytology.
Case report.
A 53-year-old man presented in October 1998 with facial spasms. His neurologic examination was normal. Brain MRI scanning revealed a nonenhancing, cystic mass anterior to the …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Deborah Friedman and Dr. Stacy Smith
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Presenting features and value of diagnostic procedures in leptomeningeal metastasesR.J. van Oostenbrugge, A. Twijnstra et al.Neurology, July 01, 1999 -
Articles
CSF levels of growth factors and plasminogen activators in leptomeningeal metastasesB. van de Langerijt, J. M. Gijtenbeek, H.P.M. de Reus et al.Neurology, July 10, 2006 -
Brief Communications
Cytologically negative carcinomatous meningitis: Usefulness of CSF biochemical markersMarc C. Chamberlain et al.Neurology, April 01, 1998 -
Resident & Fellow Section
Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal CarcinomatosisAshley E. Aaroe, Isabella C. Glitza Oliva, Nagham Al-Zubidi et al.Neurology, April 30, 2021